Mastoiditis with Streptococcus pneumoniae serotype 19A in one-dose PCV13 vaccinated three-month-old infant

---

Gülhan B., Kanik-Yuksek S., Ozkaya-Parlakay A. N.

Human Vaccines and Immunotherapeutics, vol.15, no.12, pp.2917-2918, 2019 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 15 Issue: 12
• Publication Date: 2019
• Doi Number: 10.1080/21645515.2019.1627823
• Journal Name: Human Vaccines and Immunotherapeutics
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.2917-2918
• Keywords: acute otitis media, mastoiditis, pneumococcal conjugate vaccine, Serotype 19A
• Open Archive Collection: AVESIS Open Access Collection
• Ankara Yıldırım Beyazıt University Affiliated: No

Abstract

Pneumococcal conjugate vaccines (PCV) have been widely used in high-income countries for more than a decade, resulting in a dramatic reduction in pneumococcal disease caused by vaccine serotypes. PCV has been included in Turkey’s National Immunization Programme since 2009 with PCV7 and continued with PCV13 from 2011. We presented a three-month-old infant who developed mastoiditis secondary to S. pneumoniae serotype 19A after acute otitis media.